Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study.
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity.
Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
β5 integrin is the major contributor to the αVintegrin-mediated blockade of HIV-1 replication.
RNA interference as a tool for exploring HIV-1 robustness.
Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patients.
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects.
Diarylpyrimidine-dihydrobenzyloxopyrimidine hybrids: new, wide-spectrum anti-HIV-1 agents active at (sub)-nanomolar level.
Definition of the viral targets of protective HIV-1-specific T cell responses.